Table 1 The association of SOCS2-AS1 expression in 72 endometrial cancer patients with clinicopathologic characteristics.

From: The long-noncoding RNA SOCS2-AS1 suppresses endometrial cancer progression by regulating AURKA degradation

  

SOCS2-AS1

  

Parameters

Total

Low (no.)

High (no.)

χ2

P value

Age (years)

   

1.131

0.288

<50

61

40

21

  

≥50

11

9

2

  

Histology grade

   

0.762

0.383

G1+G2

62

41

21

  

G3

10

8

2

  

Clinical stage

   

4.917

0.027

I+II

58

36

22

  

III+IV

14

13

1

  

Ki67 staining

   

5.133

0.023

<50

46

27

19

  

≥50

26

22

4

  

Pathologic type

   

0.353

0.553

Endometrioid

67

45

22

  

Non-endometrioid

5

4

1

  

Depth of myometrial invasion

   

1.647

0.199

<1/2

56

36

20

  

≥1/2

16

13

3

  

Lymph node metastasis

   

0.006

0.937

No

43

33

10

  

Yes

4

3

1

  
  1. Items with statistical differences are shown in bold.
Back to article page